GW Pharma (GWPH) Outpaces Q1 Expectations

GW Pharma (NASDAQ: GWPH) reported Q1 EPS of ($0.10), $1.43 better than the analyst estimate of ($1.53). Revenue for the quarter came in at $5.4 million versus the consensus estimate of $4.61 million.

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49